We are live on
!
Find out more
NMC
NEA Management Company Portfolio holdings
AUM
$1.76B
1-Year Est. Return
223.33%
This Fund
S&P 500
This Quarter
Est. Return
-17.94%
1 Year Est. Return
+223.33%
3 Year Est. Return
+769.45%
5 Year Est. Return
+668.45%
10 Year Est. Return
+14,843.34%
AUM
$3.46B
AUM Growth
-$1.49B
(-30%)
Cap. Flow
-$235M
Cap. Flow
% of AUM
-6.8%
Top 10 Holdings %
Top 10 Hldgs %
72.55%
Holding
60
New
2
Increased
6
Reduced
7
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ACLX
Arcellx
ACLX
|
+$108M |
| 2 |
Global E Online
GLBE
|
+$16.5M |
| 3 |
Aurinia Pharmaceuticals
AUPH
|
+$13.9M |
| 4 |
Geron
GERN
|
+$3.19M |
| 5 |
RGLS
Regulus Therapeutics
RGLS
|
+$2.08M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Robinhood
HOOD
|
+$318M |
| 2 |
CSPR
Casper Sleep Inc.
CSPR
|
+$41.6M |
| 3 |
Annexon
ANNX
|
+$10.4M |
| 4 |
Trevi Therapeutics
TRVI
|
+$6.15M |
| 5 |
LUMO
Lumos Pharma, Inc. Common Stock
LUMO
|
+$1.87M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 52.93% |
| 2 | Technology | 19.42% |
| 3 | Financials | 18.96% |
| 4 | Industrials | 5.25% |
| 5 | Communication Services | 2.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Robinhood
HOOD
$80.7B
| $644M | 18.6% |
47,664,177
-23,804,549
| -33% | -$318M |
|
|
NEUE
2
DELISTED
NeueHealth
NEUE
| $421M | 12.16% |
2,727,652
| – | – |
|
3
IonQ
IONQ
$11.9B
| $374M | 10.79% |
29,277,852
+48,193
| +0.2% | +$648K |
|
4
CRISPR Therapeutics
CRSP
$4.69B
| $366M | 10.56% |
1,590,002
| – | – |
|
5
Cloudflare
NET
$96B
| $225M | 6.49% |
1,877,510
| – | – |
|
|
BGRY
6
DELISTED
Berkshire Grey, Inc. Class A Common Stock
BGRY
| $110M | 3.18% |
38,226,621
| – | – |
|
7
Monte Rosa Therapeutics
GLUE
$1.82B
| $108M | 3.12% |
7,703,205
| – | – |
|
|
CTIC
8
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $99.8M | 2.88% |
7,140,450
| – | – |
|
9
Mirum Pharmaceuticals
MIRM
$6.56B
| $92.2M | 2.66% |
4,187,801
| – | – |
|
10
BuzzFeed
BZFD
$99M
| $72.6M | 2.1% |
3,833,473
| – | – |
|
|
ACLX
11
DELISTED
Arcellx
ACLX
| $72.2M | 2.09% |
+6,437,764
| New | +$108M |
|
|
OYST
12
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
| $69M | 1.99% |
5,925,287
| – | – |
|
|
DM
13
DELISTED
Desktop Metal, Inc.
DM
| $68.3M | 1.97% |
1,440,759
| – | – |
|
14
Rhythm Pharmaceuticals
RYTM
$7.31B
| $56.6M | 1.63% |
4,912,306
| – | – |
|
15
NextNav
NN
$1.79B
| $55.2M | 1.59% |
8,189,156
| – | – |
|
|
16
Aurinia Pharmaceuticals
AUPH
$1.95B
| $49.1M | 1.42% |
3,969,834
+900,000
| +29% | +$13.9M |
|
|
UTRS
17
DELISTED
Minerva Surgical, Inc. Common Stock
UTRS
| $40.5M | 1.17% |
500,097
+141
| +0% | +$14.3K |
|
|
ADAP
18
DELISTED
Adaptimmune Therapeutics
ADAP
| $35.2M | 1.02% |
17,082,611
| – | – |
|
19
Coursera
COUR
$1.77B
| $33.3M | 0.96% |
15,867,769
| – | – |
|
20
Nkarta
NKTX
$152M
| $33.1M | 0.95% |
2,904,974
| – | – |
|
21
Savara
SVRA
$1.08B
| $31.6M | 0.91% |
24,137,931
| – | – |
|
|
VRNA
22
DELISTED
Verona Pharma
VRNA
| $25.5M | 0.74% |
5,108,563
| – | – |
|
|
EAR
23
DELISTED
Eargo, Inc. Common Stock
EAR
| $23.9M | 0.69% |
226,034
| – | – |
|
|
24
Geron
GERN
$898M
| $22.2M | 0.64% |
16,318,681
+2,857,143
| +21% | +$3.19M |
|
|
AVEO
25
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
| $22.1M | 0.64% |
3,952,957
-1
| -0% | -$4 |
|
Similar funds
NM
SLF
CCIA
SW
CGH
PWP
CIP
KOCAA
NEA Management Company's Q1 2022 Portfolio in Review
As of Q1 2022, NEA Management Company held 60 positions worth $3.46B, down 30% from $4.95B the previous quarter. Its ten largest holdings account for 73% of the portfolio.
NEA Management Company withdrew a net $235M in Q1 2022, closing 3 positions and reducing 7 holdings. Its most notable exit was Casper Sleep Inc., an estimated $41.6M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 53% of assets, up from 41% a quarter earlier, followed by Technology and Financials.
Against the trend, NEA Management Company opened a new position in Arcellx worth $72.2M.
- NEA Management Company's largest Q1 2022 buy was Arcellx: 6,437,764 shares worth $72.2M.
- NEA Management Company added most to Aurinia Pharmaceuticals in Q1 2022, an estimated $13.9M increase.
- NEA Management Company's biggest Q1 2022 reduction was Robinhood, cutting an estimated $318M.
- NEA Management Company fully exited Casper Sleep Inc. in Q1 2022, selling an estimated $41.6M.
- NEA Management Company's ten largest holdings make up 73% of its $3.46B portfolio in Q1 2022.
- NEA Management Company opened 2 new positions and closed 3 in Q1 2022.
- NEA Management Company's portfolio value fell 30% quarter-over-quarter to $3.46B.
Based on NEA Management Company's 13F filing for Q1 2022, filed 16 May 2022.